January 9, 2021
1 min read

Modi: India all set with two ‘Made in India’ vaccines

Prime Minister of India, Narendra Modi

As India gears up for a massive vaccination drive, Prime Minister Narendra Modi on Saturday said the country is ready with two ‘Made in India’ coronavirus vaccines to save the humanity.

On January 3, two vaccines – Bharat Biotech’s Covaxin and Oxford-AstraZeneca’s Covishield manufactured by Serum Institute of India were approved for ‘restricted emergency use’. Several other vaccines are in the pipeline and are conducting trials. This vaccination drive is slated to begin by January 13.

Also Read – After barbs, vaccine makers patch up

“Earlier, India used to import PPE kits, masks, ventilators and testing kits from outside, but today it is self-reliant. Today, India is ready with two ‘Made in India’ Covid-19 vaccines to save the humanity,” Modi said at the 16th ‘Pravasi Bharatiya Divas’ convention.

The Central government plans to vaccinate nearly 30 crore people in the first phase of drive. It will be offered to one crore healthcare workers, along with 2 crore frontline and essential workers and 27 crore elderly, mostly above the age of 50 years with comorbidities.

It will be first offered to one crore healthcare workers and two crore frontline workers for ‘free’, Union Health Minister Harsh Vardhan had announced recently.

Several dry-runs have been conducted prior to the commencement of the inoculation drive.

Also Read – World’s Largest Vaccine Drive Set to Begin in India

Previous Story

Trump to skip Biden inauguration

Next Story

India captures Chinese soldier for crossing territory

Latest from -Top News

UNHRC to US: You’re Already Out

US President Donald Trump on Tuesday signed an executive order, withdrawing the US from the UNHRC…reports Asian Lite News The United Nations Human Rights Council (UNHRC) has said that as of January

‘Ozoum’ shines light on social change 

A groundbreaking Saudi television series is offering an unprecedented glimpse into the Kingdom’s social transformation, captivating domestic audiences and challenging long-standing perceptions, writes Pedro Carvalho  A groundbreaking television series is offering unprecedented
Go toTop